Education
About Us
Working with TipRanks
Follow Us
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
Earnings Data
Report Date
Aug 18, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-7.97Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Caris Life Sciences delivered an outstanding quarter with record-breaking revenue growth, improved gross margins, and positive profitability metrics. The company achieved significant milestones including a strong balance sheet and increased ASP. However, challenges remain in pharma revenue and the dependency on revenue true-ups. The complex process for MRD approval also presents a challenge.Company Guidance
Record-Breaking Revenue Growth
Total revenues increased 113% year-over-year to $216.8 million. Molecular profiling services revenues rose by over 121% year-over-year to $207.6 million.
Significant Increase in ASP
ASP increased to $4,089 per profile, representing growth of 87% year-over-year. This was primarily due to the new CMS rate of $8,455.
Improved Gross Margins
Gross margins improved significantly to 68%, up from 43.7% in the previous year.
Positive Adjusted EBITDA and Net Income
Generated positive adjusted EBITDA of $51.2 million and net income of $24.3 million. Achieved positive free cash flow of $55.3 million.
Strong Balance Sheet
Cash on hand grew to $760 million, an increase of 4.7% sequentially, providing strategic flexibility.
Clinical Case Volume Growth
Clinical case volumes grew by 18.2% year-over-year, with Caris Assure producing 66% year-over-year case volume growth.
CAI Earnings History
Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
Aug 18, 2026 | 2026 (Q2) | -7.97 | ― | ― | ― | ||
Nov 05, 2025 | 2025 (Q3) | ― | ― | ||||
Aug 12, 2025 | 2025 (Q2) | -0.319 | -2398.43% (-7.65) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CAI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $29.21 | $24.61 | -15.75% |
Aug 12, 2025 | $32.46 | $34.28 | +5.61% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Caris Life Sciences, Inc. (CAI) report earnings?
Caris Life Sciences, Inc. (CAI) is schdueled to report earning on Aug 18, 2026, After Close (Confirmed).
What is Caris Life Sciences, Inc. (CAI) earnings time?
Caris Life Sciences, Inc. (CAI) earnings time is at Aug 18, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CAI EPS forecast?
Currently, no data Available